You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ):擬增資取得固康藥業51%股權
格隆匯 06-24 19:11

格隆匯6月24日丨未名醫藥(002581.SZ)公佈,第六屆董事會第二次會議、第六屆董事會戰略決策委員會第一次會議,審議通過了《關於增資取得四川固康藥業有限責任公司51%股權的議案》,同意公司全資子公司上海未名向固康藥業增資人民幣4,500萬元,取得固康藥業51%股權。交易完成後,固康藥業將成為上海未名控股子公司,納入公司合併報表範圍。

為進一步完善醫藥產業鏈佈局,公司全資子公司上海未名擬通過增資固康藥業的方式,主動探尋公司在中藥材、中藥飲片領域及公司生物性資產市場機遇,認真謀劃資產開發思路,確定合理的運營模式,整合內外部優質資源盤活資產,推動資產運營效益提升。標的公司作為具備成熟商業化體系的中藥材及中藥飲片企業,擁有一定的市場份額與穩定的客户資源,與公司現有業務在渠道網絡及產品類型方面具有互補性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account